Healthcare Industry News: Johnson & Johnson
News Release - January 13, 2014
Align Technology Promotes Raphael Pascaud to Vice President InternationalSAN JOSE, CA--(Healthcare Sales & Marketing Network) - Align Technology, Inc. (NASDAQ: ALGN) today announced the promotion of Raphael S. Pascaud to vice president international, reporting directly to Thomas M. Prescott, Align Technology president and CEO. Mr. Pascaud assumes the position vacated by Richard Twomey, who left the Company at the end of 2013 to become CEO of a leading global healthcare products and services company.
"Raphael has been a very effective leader of our Europe, Middle East, and Africa Region for several years, driving continued growth and expansion in this largest component of our international business," said Thomas M. Prescott. "During his tenure at Align, Raphael has been recognized as a valuable member of the senior management team and I am very pleased to have him take on this new role and level of responsibility. We have a tremendous opportunity to extend our growth outside of North America and I look forward to Raphael extending his enthusiasm and expertise to our Asia Pacific and Latin America sales and marketing efforts."
Mr. Pascaud joined Align in 2010 as vice president and managing director for the Europe, Middle East and Africa Region, (EMEA). Prior to Align, Mr. Pascaud spent 14 years in various management positions within DePuy, a Johnson & Johnson family of companies, including vice president orthopedics of EMEA and vice president marketing of international. Mr. Pascaud has extensive experience in multinational organizational management, international sales strategy, and global professional and consumer marketing within the medical device sector. Mr. Pascaud holds a PhD in Bioengineering and received his undergraduate degree in Mechanical Engineering from the University of Glamorgan, Cardiff, Wales.
About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.The Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express 10, and Vivera Retainers. To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com.
Cadent Holdings, Inc. is a subsidiary of Align Technology and is a leading provider of 3D digital scanning solutions for orthodontics and dentistry. The Cadent family of products includes iTero and iOC scanning systems, OrthoCAD iCast, OrthoCAD iQ and OrthoCAD iRecord. For additional information, please visit www.itero.com.
Source: Align Technology
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.